American International Group, Inc. Arcus Biosciences, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 29,014 shares of RCUS stock, worth $425,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,014

Previous 29,266 0.86%

Holding current value

$425,055

Previous $558,000 1.97%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$14.83 - $20.18 $3,737 - $5,085	-252 Reduced 0.86%	29,014 $547,000
Q4 2023 Feb 13, 2024	BUY	$13.43 - $19.63 $3,773 - $5,516	281 Added 0.97%	29,266 $558,000
Q3 2023 Nov 13, 2023	BUY	$17.62 - $23.54 $11,752 - $15,701	667 Added 2.36%	28,985 $520,000
Q2 2023 Aug 04, 2023	BUY	$16.97 - $22.03 $3,920 - $5,088	231 Added 0.82%	28,318 $575,000
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $1,915 - $2,778	120 Added 0.43%	28,087 $512,000

Q4 2022 Feb 10, 2023	SELL	$19.7 - $35.71 $4,117 - $7,463	-209 Reduced 0.74%	27,967 $578,000
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $16,237 - $21,018	699 Added 2.54%	28,176 $737,000
Q2 2022 Aug 12, 2022	BUY	$17.23 - $37.73 $89,923 - $196,912	5,219 Added 23.45%	27,477 $696,000
Q1 2022 May 13, 2022	SELL	$28.92 - $41.83 $45,259 - $65,463	-1,565 Reduced 6.57%	22,258 $702,000
Q4 2021 Feb 11, 2022	SELL	$31.38 - $48.47 $30,564 - $47,209	-974 Reduced 3.93%	23,823 $964,000
Q3 2021 Nov 12, 2021	SELL	$26.93 - $37.68 $15,861 - $22,193	-589 Reduced 2.32%	24,797 $865,000
Q2 2021 Aug 13, 2021	BUY	$22.75 - $35.77 $18,632 - $29,295	819 Added 3.33%	25,386 $697,000
Q1 2021 May 07, 2021	BUY	$26.16 - $41.39 $1,700 - $2,690	65 Added 0.27%	24,567 $690,000
Q4 2020 Feb 12, 2021	SELL	$17.0 - $32.36 $11,951 - $22,749	-703 Reduced 2.79%	24,502 $636,000
Q3 2020 Nov 04, 2020	BUY	$17.14 - $25.47 $86,848 - $129,056	5,067 Added 25.16%	25,205 $432,000
Q2 2020 Aug 12, 2020	BUY	$13.97 - $36.56 $12,838 - $33,598	919 Added 4.78%	20,138 $498,000
Q1 2020 May 04, 2020	SELL	$8.78 - $19.28 $9,737 - $21,381	-1,109 Reduced 5.46%	19,219 $267,000
Q4 2019 Feb 05, 2020	SELL	$7.33 - $10.79 $1,260 - $1,855	-172 Reduced 0.84%	20,328 $205,000
Q3 2019 Nov 08, 2019	BUY	$6.44 - $10.18 $2,898 - $4,581	450 Added 2.24%	20,500 $187,000
Q2 2019 Aug 13, 2019	BUY	$7.29 - $13.38 $269 - $495	37 Added 0.18%	20,050 $159,000
Q1 2019 May 06, 2019	SELL	$8.95 - $12.49 $5,817 - $8,118	-650 Reduced 3.15%	20,013 $250,000
Q4 2018 Feb 13, 2019	BUY	$9.74 - $14.5 $141,259 - $210,293	14,503 Added 235.44%	20,663 $223,000
Q3 2018 Nov 09, 2018	BUY	$10.88 - $14.95 $30,398 - $41,770	2,794 Added 83.01%	6,160 $86,000
Q2 2018 Aug 08, 2018	BUY	$12.24 - $17.05 $41,199 - $57,390	3,366 New	3,366 $41,000

Others Institutions Holding RCUS

# of Institutions

186

Shares Held

49.2M

Call Options Held

204K

Put Options Held

149K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.06B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Arcus Biosciences, Inc. Transaction History